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ABSTRACT 
Objective: This research aimed to develop pH-sensitive vitamin C encapsulation using a combination of biodegradable glucomannan and alginate as 
an excipient. 
Methods: Gelation of the excipient was developed by dropping the matrix into the CaCl
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 solution to obtain beads. Various ratios of glucomannan-
alginate (1:0, 1:1, 1:3, 3:1 and 0:1, g/g), vitamin C concentrations (1, 3 and 5% of total excipient) and excipient preparation methods (mixed 
glucomannan-alginate matrix, glucomannan beads coated with alginate and alginate beads coated with glucomannan) were selected as variables. 
Entrapment efficiency of encapsulation and the release of vitamin C were determined at pH 1.2 and 6.8 which represent the pH of the stomach and 
the small intestine liquid, respectively.  
Results: Encapsulation of 3% vitamin C using 1:1 (g/g) glucomannan-alginate showed the most efficient matrix. This ratio also had lower released 
of vitamin C in pH 1.2 compared to that in pH 6.8. Coating the glucomannan bead with alginate showed better ability in encapsulating vitamin C. 
Combination excipient, as well as the addition of the vitamin C, increased the peak absorbance of the functional groups. The surface morphology of 
the encapsulation bead depended on the preparation method.  
Conclusion: An equal ratio of glucomannan and alginate (1:1, g/g) which encapsulated 3% vitamin C showed the most efficient encapsulation as 
well as lower released vitamin C in pH 1.2 compared to that in pH 6.8. Higher efficiency was observed in encapsulating vitamin C using 
glucomannan which was coated with alginate. 




Vitamin C is an indispensable nutrient required to retain the 
physiological process of human [1]. It is, however, a very unstable 
compound and easily degraded when exposed to ambient 
temperature, oxygen and light [1, 2]. Humans do not synthesize 
vitamin C due to the absence of enzyme L-gulonolactone oxidase. 
Therefore, they depend upon exogenous sources of vitamin C such 
as fruits and supplements [3]. International authorities suggest the 
Recommended Daily Intake (RDI) for adults ranging from 100-120 
mg/d to 1000 mg/d, the prudent limit. The absorption of this 
vitamin is dose-dependent, in which 80-90% of 30-180 mg/d from 
the intake is absorbed in the small intestine, and the rest mainly 
excretes in the urine. The absorption falls to less than 50% at doses 
above 1000 mg/d [4]. Hence, it is necessary to maintain low dose 
availability of this vitamin in the intestine to maximize the 
absorption.  
Since it is absorbed in small intestine, the vitamin C encapsulation 
should pass through the stomach (pH 1-2.5) in order to reach and 
absorbed in the small intestine (pH 6.6-7.5) to release the vitamin C 
[5]. Considering the dose-dependent absorption efficiency of the 
gastrointestinal, the encapsulation excipient should allow 
controlling vitamin C release at a specific rate as well as the pH-
sensitive [6]. Hence, it is necessary to design the encapsulation and 
controlled release excipient which pH-dependent to protect and 
successfully deliver vitamin C to the absorption site at the small 
intestine with the right dose. The real challenge in the development 
of an oral controlled-release drug delivery system is not only 
maintaining the sustainability of the drug, but also to prolong the 
presence of the drug within the gastrointestinal tract (GIT) until all 
the drug is completely released at the desired period [7].  
Encapsulation vitamin C has been reported using chitosan [1, 8] and 
its combination with alginate [9]. Due to the heat gel-forming ability 
[10] and the unhydrolyzed property in the stomach [11], a safe 
glucomannan meets a potential candidate for excipient of vitamin C. 
However, glucomannan solubility needs to be modified to deliver 
and control the release of vitamin C which is pH-responsive. A 
combination matrix of native glucomannan and alginate has been 
reported to increase the loading efficiency of insulin but reduce the 
release rate at pH 7.4 [12]. Moreover, this blending matrix also has 
higher water hydration at pH 7.4 solution than that at 0.1 N HCl 
solution. This condition fits to support glucomannan as an excipient 
for vitamin C controlled release. It is expected that combination 
between glucomannan and alginate as excipient brings out the best 
performance as a vitamin C controlled release. This work aimed to 
prepare pH-sensitive matrix of vitamin C controlled release using a 
combination of glucomannan and alginate. Encapsulation efficiency 
and its release performance of vitamin C were determined. The basic 
innovation of this research was to utilize the blending matrix of 
glucomannan and alginate to support the pH-sensitive matrix of 
vitamin C controlled release. 
MATERIALS AND METHODS 
Materials 
Glucomannan (80%), alginate (food grade) and vitamin C were 
bought from a local seller (Multi Kimia Raya Nusantara, Semarang-
Indonesia). CaCl2
Three methods of matrix preparations were determined. In the first 
method, a certain ratio of glucomannan and alginate was placed in 
Erlenmeyer and diluted with distilled water to 200 ml. The sol was 
stirred at 300 rpm for 15 min. Vitamin C was added to the solution 
as designed (300 mg). The mixture was dropped into a stirred CaCl




solution (0.2 N, 100 ml) using a syringe. After one h, the beads were 
collected and freeze-dried. The bead was subject to encapsulation 
performance analysis.  
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The second and the third methods of encapsulation preparations 
were conducted to observe the effect of the coating of vitamin C 
bead on its characteristics. An excipient ratio obtained from the first 
method which provided the highest entrapment efficiency was used 
to evaluate the coating effect. A sole matrix, either glucomannan or 
alginate, and vitamin C were diluted together in 200 ml distilled 
water. After dropping in the CaCl2 solution, the beads were collected 
and dried. These dried beads were subsequently suspended to 200 
ml of the other sole excipient solution and followed with the 
dropping process. The beads were collected and freeze-dried. All the 
methods were repeated three times. 
Vitamin C entrapment efficiency 
Entrapment efficiency was defined as the amount of vitamin C that 
successfully entrapped in the excipient. The bead (3 mg) was diluted 
with 10 ml of distilled water. After centrifugation, the supernatant 
was read at 266 nm of spectrophotometer UV-Vis. The absorbance 
was compared to vitamin C standard curve. The efficiency was 
calculated base on the actual amount of vitamin C found in the bead 
(L) divided by the amount of vitamin C added in the encapsulation 
process (Lo) (1). 
Entrapment efficiency of vitamin C =  ……. (1) 
The release of vitamin C 
The release of vitamin C was modified from the method of Desai et 
al. [13]. The release was determined at two-pH solutions of 37 °C 
and stirrer at 50 rpm. The bead (30 mg) was diluted in pH 1.2 of HCl 
solution (8 ml, 0.1 M) which represent pH of stomach liquid. The 
same weight of the bead was diluted in the phosphate buffer 
solution (pH 6.8) which represent the small intestine liquid. One ml 
of each solution was taken and diluted necessarily before the 
absorbance reading using spectrophotometer UV-VIS at 266 nm. The 
concentration of vitamin C was compared to the standard curve of 
vitamin C. The release of vitamin C represents an accumulation of 
released vitamin C in a particular period. 
Functional groups and morphology 
The functional groups and surface morphology of the bead were 
determined using IR Prestige Shimadzu and FEI Inspect S50, 
respectively. The peaks of the groups were assigned with the 
literature data. The surface morphology was observed in a certain 
magnification.  
RESULTS AND DISCUSSION 
Since vitamin C has a high solubility, the excess supply of this 
vitamin is discharged from the human body [14]. On the other hand, 
the human body lack of enzyme L-gulonolactone oxidase which 
produced vitamin C [15]. Hence, vitamin C needs to be encapsulated 
to manage its presence in the body. In this study, a combination of 
glucomannan and alginate was used as an encapsulant of vitamin C. 
In this work, the ratio of glucomannan and alginate (1:0, 1:1, 1:3, 3:1 
and 0:1, g/g), the concentration of vitamin C (1, 3 and 5% of total 
excipient weight) and the encapsulation method preparation were 
selected as variables. The encapsulated vitamin C was subject to the 
efficiency of encapsulation and the release of vitamin C, which 
determined at pH 1.2 and 6.8.  
This work was conducted in 2 stages. In the first stage where the 
effect of the ratio of encapsulant and concentration of vitamin C was 
studied, both excipients and vitamin C were blended followed by the 
encapsulation process by dropping in CaCl2
The second stage focused on the effect of encapsulation preparation. 
Firstly, vitamin C was blended with one of the encapsulant material 
followed by dropping to CaCl
 solution. The expected 
output of the first stage was the ratio and concentration of vitamin C 
which had high efficiency as well as supported the vitamin C 
protection in pH stomach and delivered the vitamin into the 
intestine sites.  
2 solution and drying process. The 
obtained beads subsequently were suspended to the other 
encapsulant suspension before dropping to the CaCl2 prior to be 
freeze-dried to obtain the encapsulated vitamin C. 
 
 
Fig. 1: Effect of vitamin C concentration, the ratio of glucomannan-alginate and preparation methods on the encapsulation efficiency, 
*results are expressed as mean±SD, n=3 (GM=glucomannan, AL=alginate) 
 
Wardhani et al. 
Int J App Pharm, Vol 11, Issue 2, 2019, 185-192 
187 
Entrapment efficiency 
The efficiency was described as the ability of the excipient to trap 
the active compound compared to the active compound added 
during the loading. Fig. 1 shows the ratio of combination excipient 
and the concentration of vitamin C affected the efficiency. The use of 
sole glucomannan as the excipient (1:0, g/g) resulted in lower 
efficiency. The sole alginate (0:1, g/g) showed higher efficiency than 
that of the sole glucomannan (1:0, g/g) in encapsulating 3% vitamin 
C. Native glucomannan did not form a gel. However, the 
glucomannan gel was induced by the alkaline condition. In this 
work, the glucomannan solution was dropped into CaCl2 solution 
which could help in creating the gel by changing the glucomannan 
chain from semi-crimping to self-crimping. This crimping leads to 
self-aggregation between the molecules [16]. The gel properties 
themselves subject to deacetylation degree. Meanwhile, the alginate 
forms the beads prior to dropping into CaCl2 solution which used as 
a crosslinking agent in this study. Alginate is negatively charged of 
polysaccharide which able to react with divalent cations, in this case, 
is Ca2+ions of CaCl2
Increasing concentration of vitamin C in the matrix affected the 
encapsulation efficiency. Higher vitamin C concentration tended to 
increase the efficiency until in a certain condition the capacity of the 
matrix to entrap vitamin C reached the maximum. This could be due 
to unbalance interaction between the excipient and vitamin C which 
resulted in decreasing the efficiency. The initial concentration of 
encapsulated vitamin C is shown in table 1. A linear correlation 
between the active compound and the excipients was observed. 
Vitamin C is a polar organic compound which has hydroxyl groups 
on its structure. These groups could interact and form hydrogen 
bonding with the glucomannan-alginate, hence, increase the 
efficiency of higher vitamin C concentration. However, encapsulation 
using ratio glucomannan-alginate 1:1 (g/g) had a lower efficiency 
than that of other ratios when the concentration of vitamin C was 
high (5%). This higher concentration allowed to interrupt more 
hydrogen bonding of the matrix and reduced entrapped vitamin C. 
The results suggested that the efficiency of encapsulation was not 
only relied on the excipient capability to entrap the amount of the 
vitamin C, but also the internal synergism of the excipients and the 
external interaction between excipient and the active compound. 
Moreover, the interaction between the excipient and the 
crosslinking agent could also contribute to the efficiency of 
encapsulation. 
Comparison of encapsulation preparation method on the efficiency 
of 3% of vitamin C was illustrated in fig. 1, which shows all the 
efficiencies of various encapsulation methods were higher than 
80%. There was no superior encapsulation method in term of 
efficiency. Overall, the first and second encapsulation method had 
better performance efficiency than that of the third method. The 
highest encapsulation efficiency (96.84%) was performed using the 
first method of the ratio of glucomannan-alginate 3:1 (g/g). This 
highest in efficiency could be in relation with its viscosity. Wardhani 
et al. [18] reported this 3:1 ratio of glucomannan-alginate has the 
highest viscosity compare to other ratios.  
In this work, the gelation process was conducted by dropping the 
excipient solution into the CaCl
 solution to produce a strong gel [17]. It seems 
that the gelation condition of this study implied better bead 
properties on alginate than that on glucomannan. Hence, more 
vitamin C was trapped in the gel as the alginate was crosslinked with 
a divalent cation to form a bead. 
Fig. 1 shows changing the ratio of the matrix impacted to the 
efficiency. Changing the ratio of the excipient created different 
viscosities of the excipient, as also reported by Wardhani et al. [18]. 
Variation in viscosity could affect the gel formation of the excipients 
which in turn influences the size of the bead as well as the capability 
of the matrix to entrap the vitamin. Bhujbal et al. [19] reported 
viscosity of matrix and the size of the beads are among factors in 
determining the strength of alginate-based encapsulation. 
Glucomannan is a non-ionic polysaccharide which unable to form a 
strong gel in the presence of divalent ions. This inability could lead 
to release the vitamin C from the bead. As a result, the efficiency of 
vitamin C encapsulation decreased in a higher ratio of glucomannan. 
Meanwhile, increasing alginate was expected to improve the cross-
link densities, enhance mechanical strength and compactness of the 
bead. However, the inverse result was observed in this study. 
Alginate was reported to have porosities [20]. Hence, the loss of 
vitamin C from the bead could be due to the porosity of alginate. 
Increasing alginate concentration provided more porosity which 
facilitated more loss of vitamin C. 
In general, a combination of this alginate with glucomannan in the 
same ratio (1:1, g/g) created a positive interaction and resulted in 
the highest efficiency (95.82%). This combination of the equal 
weight of polysaccharides allowed to form many hydrogen bonds 
which helped in entrapping vitamin C. The hydrogen bonds were not 
only formed intern of each molecule of glucomannan or alginate but 
also existed between these two polysaccharides. Zhen et al. [21] 
suggested a large number of hydrogen bonds could be created 
between glucomannan and alginate which mainly occurred 
between-OH on position C6 and C3 of mannose residues of 
glucomannan and C in position 2 and 3 of sodium alginate. The 
blending of glucomannan and alginate lead to a positive synergistic 
effect, because the chain segments of glucomannan surround the 
sodium alginate molecules spirally and irregularly, leading to the 
strong nonbonding intermolecular forces which tend to form stable 
conformations [21]. Hence, a similar ratio of combination excipient 
could contribute similar interaction in protecting and trapping 
vitamin C which results in higher encapsulate efficiency.  
2 solution. Since alginate formed 
better gelation than glucomannan in CaCl2
Fig. 3 illustrates the accumulation of released vitamin C at various 
vitamin C initial concentrations in which the releases were in line 
with release time. Higher concentration of the entrapped vitamin C 
led to increasing the release rate at both pHs. Hence, a lower initial 
concentration of vitamin C was preferred to reduce the release rate. 
Unfortunately, accumulation of release of 1% vitamin C was low in 
both pHs which were not a favor too. Encapsulation of 3% vitamin C 
showed the most compromise release in both pHs. This result shows 
that the excipient has a maximum loading capacity. Hence, in some 
points, increasing concentration of the active compound induced the 
release. This work suggested that 3% vitamin C could give a balance 
between high ability to trap and low release vitamin C. Among the 
ratios of glucomannan-alginate, the excipient of 3:1 (g/g) performed 
lower accumulation in pH 1.2 but reverse accumulation observed in 
pH 6.8. Hence, this ratio was used in the next step of the study which 
focused on the encapsulation preparation methods. 
, hence coating the 
glucomannan encapsulation with alginate as the outer layer had 
helped to protect trapped vitamin C. When glucomannan was 
applied as an outer layer, higher alginate concentration has 
facilitated to trap more vitamin C in ratio 1:3 (g/g) of glucomannan-
alginate. This result corroborated with previous research which 
found that alginate contributed to increasing the encapsulation 
efficiency [12]. However, more rigid and higher mechanical strength 
of the matrix was produced when the concentration of alginate was 
much higher than that of glucomannan. This efficiency was because 
only a certain amount of vitamin C can be absorbed into the matrix 
of alginate [22] and resulted in higher efficiency.  
Vitamin C release 
Another objective of this work was to maintain a low concentration 
of vitamin C existence in body liquid and less of the vitamin C 
excesses was discharged from the body. It was expected that the 
encapsulant protects the vitamin C from the digesting process in the 
stomach which has pH 1.2. Moreover, the encapsulant should be able 
to deliver vitamin C to the small intestine where the vitamin is 
absorbed via a sodium-dependent active transport mechanism. The 
absorption efficiency gradually decreases at higher intakes of 
vitamin C [4]. 
The release performance of vitamin C encapsulation in 2-pHs is 
presented in fig. 2. In general, the release of vitamin C was pH-
dependent. Higher concentrations of vitamin C were released at pH 
1.2 (fig. 2-top) than those at pH 6.8 (fig. 2-bottom). 
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Fig. 2: Effect of various ratio of combined matrix encapsulation on the release profile of vitamin C at pH 1.2 (top) and pH 6.8 (bottom), 
*results are expressed as mean±SD, n=3 
 
Table 1: The amount of encapsulated vitamin C (g) per batch for various variables 
The ratio of glucomannan-alginate (g/g) Added vitamin C (g)/batch Matrix preparation methods Entrapment vitamin C (g)/batch 





1:1 1 0.76±0.18 
0:1 0.76±0.20 
3:1 0.73±0.12 
1:1 5 4.31±0.78 
0:1 4.86±0.94 
3:1 4.80±0.36 
1:1 3 (GM+Vit C)+AL 2.78±0.36 b) 
3:1 2.91±0.28 
1:3 2.51±0.24 
1:1 3 (AL+Vit C)+GM 2.54±0.33 c) 
3:1 2.72±0.39 
1:3 2.87±0.43 
a)First method: glucomannan, alginate, and vitamin C were mixed before beading, b)Second method: beads of glucomannan and vitamin C were 
coated with alginate, c)Third method: beads of alginate and vitamin C were coated with glucomannan, *results are expressed as mean±SD, n=3 
Wardhani et al. 




Fig. 3: Effect of concentration of 3% vitamin C on the release profile of vitamin C at pH 1.2 (top) and 6.8 (bottom), *Results are expressed 
as mean±SD, n=3 
 
In this work, the encapsulation was applied to manage the release rate 
of vitamin C which controls by the pH of the simulated-digestion 
liquid. Fig. 3 shows the release rate of vitamin C from the matrix was 
faster in the intestine liquid-like than in the stomach, especially during 
the first two hour. The 1:1 (g/g) matrix of 3% vitamin C was the one 
that has a relative low release in both pHs. The use of a combination 
matrix could adversely affect to extend the period of the drug release 
profile. This combination allows forming the perfect interaction of 
glucomannan, alginate and vitamin C which mediated by hydrogen 
bonding to trap and control the release of vitamin C.  
Effect of encapsulation method on profile release of vitamin C at pH 
1.2 (top) and pH 6.8 (bottom) is presented in fig. 4. The majority of 
the encapsulation method samples had low rate release in both pHs, 
except for the samples of ratio 1:3 of the first method. The first 
method encapsulation had higher release rate in pH 1.2 than that of 
pH 6.8. This high release seemed to relate with low efficiency as 
presented in fig. 1.  
Alginate is less soluble in the acid liquid of stomach than in small 
intestine [23] which help in controlling release vitamin C. It consists 
of high content of the manuronate (M) group which is suitable in 
thickening applications, while the guluronate (G) group is best for 
gelation [24]. However, a high concentration of alginate could cause 
difficulties for vitamin C to be released due to increasing gelation. 
Therefore, a combination of alginate and glucomannan can maintain 
in trapping and releasing water-soluble vitamin C. A lower release 
value was observed when glucomannan was applied as the outer 
layer of the matrix (the second preparation method). Previous 
research reported that sole glucomannan matrix shows a high value 
of control release [25]. 
The functional groups 
The functional group comparison of alginate, glucomannan, vitamin C as 
well as their combinations is presented in fig. 5. All matrixes materials 
have similar peaks in the range of 400-4000 cm-1, except those of the 
ascorbic acid. The peaks of glucomannan are in agreement with Chua et 
al. [26] and Wardhani et al. [27]. The native glucomannan has a wide 
band of the peak at ~3400 cm-1 which attributed to O-H stretching 
vibration. Some other peaks which also detected in glucomannan matrix 
in range of 1000-2000 cm-1 are carbonyl of acetyl groups (~1730 cm-1) 
angular deformation of C-H (~1410 and 1370 cm-1) and C-O-C ether 
bond stretching (~1150 cm-1 and ~1070 cm-1). Chua et al. [26] also 
reported the presence of the peaks at ∼870 cm−1and ∼800 cm−1
The native alginate has also an O-H stretching band (~3400 cm
 which 
attributed to β-glucosidic and β-mannosidic linkages in glucomannan. 
-1), O-
C=O asymmetric stretching group (~1610 cm-1), O-C=O asymmetric 
stretching (~1420 cm-1), similar as reported by Huang et al. [28]. 
Gomez-Ordonez and Ruperez [29] reported the peaks of alginate 
sample also found at ~1080 cm-1and ~1020 cm-1 bands which 
assigned to C-O and C-C stretching vibrations of pyranose ring and C-
O-C glycosidic bonds. Moreover, Wang et al. [30] reported four peaks 
are detected in the fingerprint region of carbohydrates in alginate 
(950–750 cm−1). The weak peaks at ~940 and ~930 cm−1 are assigned 
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to C–O stretching in pyranose rings and α-bond in polysaccharide 
chains. Two other peaks at ~875 and ~800 cm−1
Both Chua et al. [26] and Huang et al. [28] reported a–CH
 are characteristic of 
guluronic and mannuronic acid groups, respectively [29]. 
2-
stretching vibration at ~2900 cm-1 band was found in glucomannan 
and alginate. Interestingly, either lone glucomannan or lone alginate 
did not show a clear peak around ~2900 cm-1 which assigned to C-H 
group. This peak is observed only in the combination matrixes. The 
peak suggested that although each of glucomannan, alginate and 
vitamin C had unnoticeable absorbance of the stretching groups, this 




Fig. 4: Effect of encapsulation method of vitamin C on the release profile of vitamin C at pH 1.2 (top) and pH 6.8 (bottom), *Results are 
expressed as mean±SD, n=3 
 
Fig. 5: Functional groups of various preparations of vitamin C encapsulation 
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Fig. 6: Morphology of encapsulated 3% vitamin C using 
various preparation methods: glucomannan and alginate (3:1, 
g/g) were blend together with the vitamin C (top), bead of 
three-parts of glucomannan and vitamin C which coated with 
one-part alginate (middle), bead of one part of alginate and 
vitamin C which coated with three-parts of glucomannan 
(bottom) 
Bead morphologies 
The surface morphologies of encapsulate vitamin C prepared with 
three methods are described in fig. 6. The first method which 
blended glucomannan, alginate and vitamin C all together resulted in 
the bead surface covered by a group of rough square particles in 
some spots (fig. 6-top). When vitamin C was firstly encapsulated 
with glucomannan followed by alginate coating, the excipient mostly 
covered by the square separated particles (fig. 6-middle). 
Meanwhile, the fused particle covered the surface of the 
encapsulation when glucomannan was applied to cover the 
encapsulated vitamin C with alginate (fig. 6-bottom). 
CONCLUSION 
The most efficient encapsulation was prepared using a similar ratio 
of glucomannan and alginate (1:1, g/g) for encapsulate 3% vitamin 
C. This ratio showed lower released vitamin C in pH 1.2 compared to 
that in pH 6.8. Coating the vitamin C-glucomannan bead with 
alginate showed better ability in encapsulating vitamin C. The 
absorbance of all combination of excipient increased in most of the 
peaks of the functional groups. The surface profile of the bead 
depended on the encapsulation preparation method.  
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